MedPath

Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot

Not Applicable
Conditions
AIDS
Hepatitis B
Hepatitis C
Registration Number
NCT05390424
Lead Sponsor
University Hospital, Rouen
Brief Summary

The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Former or active intravenous and/or nasal drug user
  • Person on opiate substitution therapy
Exclusion Criteria
  • Person with known active viral infection(s)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of person with an active AIDS infectionDay 1
Number of person with an active hepatitis C infectionDay 1
Number of person with an active hepatitis B infectionDay 1
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CSAPA la Boussole

🇫🇷

Rouen, France

CSAPA la Boussole
🇫🇷Rouen, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.